American Healthcare REIT, Inc.
AHRNYSECIK 1632970Real estateFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1820:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-395604 |
| 2026-09-1410:35 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-389802 |
| 2026-09-0221:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-380473 |
| 2026-09-0120:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-378483 |
| 2026-08-2420:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363616 |
| 2026-08-1220:16 ET | 8-K | 8.01 Other events | 0001193125-26-346895 |
| 2026-08-1020:06 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-342358 |
| 2026-08-0720:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340269 |
| 2026-08-0620:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338076 |
| 2026-07-2220:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312419 |
| 2026-06-2520:29 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-282860 |
| 2026-06-1820:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-275899 |
| 2026-05-2820:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-245272 |
| 2026-05-2220:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-236930 |
| 2026-05-0820:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214678 |
| 2026-05-0720:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212023 |
| 2026-04-0920:18 ET | DEF 14A | Proxy statementPeriod 2026-04-09 | 0001193125-26-149677 |
| 2026-04-0720:39 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-145647 |
| 2026-03-2420:26 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-121898 |
| 2026-03-1820:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-114004 |
| 2026-02-2722:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-083247 |
| 2026-02-2721:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-082692 |
| 2026-02-2621:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-076786 |
| 2026-02-0421:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-037696 |
| 2025-12-1621:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320892 |
| 2025-11-2621:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-300540 |
| 2025-11-2421:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-293711 |
| 2025-11-0721:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272390 |
| 2025-11-0622:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-270069 |
| 2025-09-1820:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-207494 |
| 2025-08-0820:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001632970-25-000064 |
| 2025-08-0820:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001632970-25-000063 |
| 2025-08-0720:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000057 |
| 2025-06-2620:22 ET | 8-K | 5.07 Shareholder vote results | 0001632970-25-000050 |
| 2025-06-2020:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-25-000046 |
| 2025-05-0920:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001632970-25-000042 |
| 2025-05-0901:52 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001632970-25-000040 |
| 2025-05-0820:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000037 |
| 2025-04-1020:15 ET | DEF 14A | Proxy statementPeriod 2025-04-10 | 0001632970-25-000027 |
| 2025-03-1921:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-25-000021 |
| 2025-02-2821:57 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001632970-25-000018 |
| 2025-02-2721:16 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000013 |
| 2025-02-2421:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001632970-25-000006 |
| 2024-12-1821:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000134 |
| 2024-11-1814:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001632970-24-000125 |
| 2024-11-1319:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001632970-24-000121 |
| 2024-11-1221:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-24-000119 |
| 2024-11-0821:21 ET | 8-K | 5.07 Shareholder vote results | 0001632970-24-000114 |
| 2024-09-2020:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000106 |
| 2024-09-0620:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000101 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.